← Back to Clinical Trials
Recruiting NCT07131215

NCT07131215 Smart Technology-Based Intervention and Monitoring of Physical and Mental Health in Early Postmenopausal Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07131215
Status Recruiting
Phase —
Sponsor YI-JU TSAI
Condition Postmenopausal
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2025-08-15
Primary Completion 2028-07-30

Eligibility & Interventions

Sex Female only
Min Age 40 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Home-based multimodal exerciseSupervised multimodal exercise programEducation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2025-08-15 with a primary completion date of 2028-07-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to compare the short-term and long-term effects of an 8-week home-based multimodal exercise program, delivered through a smartphone app, on quality of life, muscle function, and physical performance in early postmenopausal women.

Eligibility Criteria

Inclusion Criteria: * 45 to 65-year-old postmenopausal women * At least 12 months of amenorrhea * Within 6 years after menopause Exclusion Criteria: * Exercised more than twice a week for at least 30 minutes per session * Received hormone therapy in the past three months * Neurological disease (e.g., spinal cord injury, multiple sclerosis, stroke) or cardiovascular diseases * History of pelvic or prolapse surgery (excluding cesarean section) * History of malignancy affecting the bladder, urethra, uterus, ovary, cervix, or rectum * Using medications that could affect heart rate or mood * Body mass index (BMI) \> 35 kg/m²

Contact & Investigator

Central Contact

Yi-Ju Tsai PhD

✉ yijutsai@mail.ncku.edu.tw

📞 +886-6-2353535 Ext. 5021

Frequently Asked Questions

Who can join the NCT07131215 clinical trial?

This trial is open to female participants only, aged 40 Years or older, up to 65 Years, studying Postmenopausal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07131215 currently recruiting?

Yes, NCT07131215 is actively recruiting participants. Contact the research team at yijutsai@mail.ncku.edu.tw for enrollment information.

Where is the NCT07131215 trial being conducted?

This trial is being conducted at Tainan, Taiwan.

Who is sponsoring the NCT07131215 clinical trial?

NCT07131215 is sponsored by YI-JU TSAI. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology